银屑病关节炎患者的疼痛机制与超声炎症活动作为预后因素:一项前瞻性队列研究
该探索性前瞻性队列研究纳入69例起始生物制剂或传统合成改善病情抗风湿药的银屑病关节炎患者,基线时35%存在广泛非关节炎性疼痛(WP),WP与更差的患者报告评分及4个月时未达到最小疾病活动度相关(OR 18.43,95%CI 1.51, 224.41;P=0.022),而基线彩色多普勒超声活动对后续治疗反应无影响。
要点
- 35%的银屑病关节炎患者存在广泛非关节炎性疼痛,与更差的患者报告评分相关。
- 无广泛非关节炎性疼痛者4个月达到最小疾病活动度的比值比为18.43(95%CI 1.51, 224.41;P=0.022)。
- 基线彩色多普勒超声活动不影响后续治疗反应。
核心结论
- 超过三分之一的银屑病关节炎患者存在广泛非关节炎性疼痛,与更差的患者报告评分及传统合成或生物改善病情抗风湿药治疗后未达到最小疾病活动度相关。
- 彩色多普勒超声评估的银屑病关节炎活动度在该队列中对后续治疗反应无影响。
研究设计与样本
- 探索性前瞻性队列研究,纳入69例在常规诊疗中起始生物制剂或传统合成改善病情抗风湿药的银屑病关节炎患者。
- 基线和4个月后收集临床、超声及患者报告指标,主要分析为年龄和性别校正的logistic回归。
主要发现
- 69例中24例(35%)存在广泛非关节炎性疼痛,其患者报告和复合基线指标更差,而超声及其他客观发现与无广泛非关节炎性疼痛者相似。
- 无广泛非关节炎性疼痛者4个月后达到最小疾病活动度的比值比为18.43(95%CI 1.51, 224.41;P=0.022),广泛非关节炎性疼痛未损害其他反应指标。
- 基线彩色多普勒活动者42例(61%),其客观银屑病关节炎负担更差,但治疗反应机会与无彩色多普勒活动者相当。
关键数值与推荐
- 广泛非关节炎性疼痛定义为广泛疼痛指数评分≥4分且5个区域中≥4个区域存在疼痛。
- 超声银屑病关节炎活动度定义为选定附着点、关节或肌腱中彩色多普勒信号存在(是/否)。
- 主要反应标准包括美国风湿病学会20%改善、银屑病关节炎疾病活动度50%改善和最小疾病活动度。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To study the prognostic value of widespread pain and of musculoskeletal ultrasound (US) examination for subsequent treatment outcomes in patients with psoriatic arthritis (PsA). METHODS: An exploratory prospective cohort study enrolled patients with PsA initiating biologic or conventional synthetic disease-modifying antirheumatic drugs in routine care. Clinical, US, and patient-reported measures were collected at baseline and after 4 months. Widespread nonarthritic pain (WP) was defined as a Widespread Pain Index score of ≥4 with pain in ≥4 of 5 regions. PsA activity by US was defined as color Doppler (yes/no) in selected entheses, joints, or tendons. The main response criteria included the American College of Rheumatology 20% improvement, the Disease Activity in Psoriatic Arthritis 50% improvement, and minimal disease activity. The primary analyses were age- and sex-adjusted logistic regression. RESULTS: WP was present in 24 of 69 included patients (35%) and was associated with worse patient-reported and composite baseline measures, while US and other objective findings were similar to those in patients without WP. The odds of reaching minimal disease activity after 4 months were significantly greater for patients enrolled without WP (odds ratio 18.43 [95% confidence interval 1.51, 224.41]; P = 0.022), while WP did not impair other response measures. Patients with baseline color Doppler activity (n = 42 [61%]) had a worse objective PsA burden, but their chance of treatment response was comparable to those without color Doppler. CONCLUSION: More than one-third of patients with PsA presented with WP, which was associated with worse patient-reported scores and failure to achieve minimal disease activity following conventional synthetic or biologic disease-modifying antirheumatic drug therapy. PsA activity by color Doppler US had no influence on subsequent treatment response in this PsA cohort.
引用
- Højgaard P, Ellegaard K, Nielsen SM, et al. Pain Mechanisms and Ultrasonic Inflammatory Activity as Prognostic Factors in Patients With Psoriatic Arthritis: A Prospective Cohort Study. Arthritis Care Res (Hoboken). 2019. PMID: 29975012. doi:10.1002/acr.23693
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。